Quick Answer
Pyxis Oncology, Inc. reported Total Assets of $91.52 million for fiscal year 2025.
Pyxis Oncology, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $91.52M | -41.8% |
| 2024 | $157.18M | -9.5% |
| 2023 | $173.73M | -17.8% |
| 2022 | $211.38M | -24.5% |
| 2021 | $280.02M | +2658.6% |
| 2020 | $10.15M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $105.60M | -45.9% | -14.3% |
| June 30, 2025 | $123.22M | -40.9% | -9.3% |
| March 31, 2025 | $135.87M | -38.3% | -13.6% |
| December 31, 2024 | $157.18M | -9.5% | -19.5% |
| September 30, 2024 | $195.31M | +4.6% | -6.3% |
| June 30, 2024 | $208.39M | +18.9% | -5.4% |
| March 31, 2024 | $220.22M | +20.5% | +26.8% |
| December 31, 2023 | $173.73M | -17.8% | -6.9% |
- Pyxis Oncology, Inc. showed a decrease of -41.8% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Pyxis Oncology, Inc.’s total assets has grown by 801.6% (from $10.15 million to $91.52 million).
- The most recent figure is from Pyxis Oncology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: